Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.190
-0.060 (-1.85%)
At close: Feb 27, 2026, 4:00 PM EST
3.160
-0.030 (-0.94%)
After-hours: Feb 27, 2026, 4:10 PM EST
Evaxion Employees
Evaxion had 46 employees as of December 31, 2024. The number of employees decreased by 3 or -6.12% compared to the previous year.
Employees
46
Change (1Y)
-3
Growth (1Y)
-6.12%
Revenue / Employee
$166,304
Profits / Employee
-$117,783
Market Cap
26.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Kyntra Bio | 225 |
| IO Biotech | 78 |
| IGC Pharma | 70 |
| Boundless Bio | 64 |
| Passage Bio | 60 |
| Cue Biopharma | 41 |
| Senti Biosciences | 34 |
| BriaCell Therapeutics | 16 |
EVAX News
- 6 weeks ago - Evaxion expands AI-Immunology™ platform into autoimmune diseases - GlobeNewsWire
- 7 weeks ago - Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week - GlobeNewsWire
- 2 months ago - Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Benzinga
- 2 months ago - Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2 - GlobeNewsWire
- 3 months ago - Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting - GlobeNewsWire
- 3 months ago - Evaxion announce 2026 financial calendar - GlobeNewsWire
- 4 months ago - Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 - GlobeNewsWire
- 4 months ago - Evaxion A/S (EVAX) Q3 2025 Earnings Call Transcript - Seeking Alpha